content_image/63554.jpg content_image/63555.jpg
The proceeds from sales of available-for-sale securities for the years ended March 31, 2002 and 2001 were ¥29,714 million ($223,414 thousand) and ¥23,774 million, respectively. The gross realized gains on those sales for the years ended March 31, 2002 and 2001 were ¥9,474 million ($71,233 thousand) and ¥5,443 million, respectively. The gross realized losses on those sales for the years ended March 31, 2002 and 2001 were ¥644 million ($4,842 thou- sand) and ¥1,992 million, respectively. 

The Company recorded a charge of ¥27,572 million ($207,308 thousand) related to other-than-temporary declines in the marketable and non-marketable equity securities for the year ended March 31, 2002, which is includ- ed in other expenses. 

## 5. FINANCE RECEIVABLES AND SECURITIZATIONS 

Investment in financing leases consists of sales-type and direct financing leases mainly for information systems, med- ical equipment, industrial equipment and others. 

Other finance receivables represent transactions in a variety of forms, including commercial loans, and installment sales of consumer products manufactured by the Company. 

Finance receivables comprise the following: 

<img src='content_image/63554.jpg'>

At March 31, 2002, the contractual maturities of minimum lease payments of the investment in financing leases and the other finance receivables are as follows: 

<img src='content_image/63555.jpg'>

